The idea of testing the Bacille Calmette-Guerin (BCG) vaccine in Africa against COVID-19 was bound to cause controversy, yet officials say efforts under way could, if successful, give the continent a cheap and easily deployable weapon against the virus.
South African biotech group TASK Applied Science this month started the continent’s first trial to see whether 250 high-risk workers given a booster dose of BCG vaccine showed better protection against COVID-19 than the same number given a placebo.
Three thousand health workers are eventually expected to be involved in the trial overall. Researchers expect preliminary results within six months in the year-long trial.
Tests to see if the century-old BCG vaccine, widely used in Africa for tuberculosis, protects against the novel coronavirus have also begun in the Netherlands and Australia.
Yet unlike those countries, where BCG vaccinations at birth are not the norm, South Africa’s trial involves injecting people for a second time. BCG injections are mandatory at birth in South Africa, where tuberculosis is a leading killer.
“We are trying to see if ... reminding the immune system of that vaccine will make a difference,” said Andreas Diacon, a professor at Stellenbosch University’s medical school who founded TASK in 2005 to hunt for novelty medicines and vaccines.
“Perhaps it works, perhaps it doesn’t, but it’s definitely worth trying ... [because] we just need to know if it can help us through this COVID-19 crisis,” he told reporters at TASK’s high-security mycobacteriology laboratory.
Trying out a new medical intervention in Africa always rings alarm bells, because of an unfortunate history of big pharmaceutical companies using Africans as guinea pigs.
So when a French doctor last month suggested that the BCG should also be tested in Africa as a possible shield against COVID-19, it provoked a predictable social media backlash.
Yet the vaccine is widely regarded as safe, and officials involved in the trial at Tygerberg Hospital in Cape Town say that it is so readily available in Africa and the developing world that poor countries with limited health resources could benefit massively from the discovery that the injection is effective.
“If you look at BCG as a potentially cheap and available tool that African countries could afford ... it does make sense,” Diacon said. “The results will be relevant for ... parts of the world that do not have access to first world medicine.”
The WHO has said that the next epicenter of the pandemic could very well be Africa, where measures to contain it are harder to implement and health services much more likely to be overwhelmed than in the West.
Across Africa, there is less than one intensive care bed and one ventilator per 100,000 people, a Reuters survey found.
The continent has about 85,329 confirmed coronavirus cases and 2,784 deaths, compared with more than 323,000 worldwide since the virus emerged in China late last year.
“Our experts have ensured stringent ... criteria for trial participants, as well as all the requisite safety and efficacy monitoring measures during the trial,” a South African Health Products Regulatory Authority spokesman said.
‘OBVIOUS DIFFERENCE’: The Wuhan Institute of Virology has been researching bat coronaviruses to trace the SARS pathogen, which is 80 percent similar to SARS-CoV-2 The Chinese virology institute in the city where COVID-19 first emerged has three live strains of bat coronavirus on-site, but none match the new contagion wreaking havoc around the world, its director has said. Scientists think COVID-19 — which first emerged in Wuhan and has killed more than 340,000 people worldwide — originated in bats and could have been transmitted to people via another mammal. However, the director of the Wuhan Institute of Virology told state broadcaster China Global Television Network that claims made by US President Donald Trump and others that the novel coronavirus could have escaped from the facility were
SPACE RACE: The China Aerospace Science and Technology Corp mission aims to land a robotic rover and put a probe into orbit around the planet China is targeting a July launch for its ambitious Mars mission, which includes landing a remote-controlled robot on the surface of the Red Planet, the company in charge of the project has said. Beijing has invested billions of dollars in its space program in an effort to catch up with its rival, the US, and affirm its status as a major world power. The Mars mission is among a number of new space projects China is pursuing, including putting Chinese astronauts on the moon and having a space station by 2022. Beijing had been planning the Mars mission for some time this year,
India has moved additional troops along its northern border as it prepares for an extended conflict with China, after several rounds of talks failed to ease tensions between the nuclear-armed rivals. China has already placed about 5,000 soldiers and armored vehicles within its side of the disputed border in the Ladakh region, an Indian government official said, asking not to be identified, citing rules. India is adding a similar number of troops as well as artillery guns along the border to fend off the continuing incursions by the Chinese army, the official said. The standoff began on May 5, when troops clashed
China is poised to enshrine individuals’ rights to privacy and personal data for the first time, a symbolic first step as more of the country of 1.4 billion people becomes digitized — and more vulnerable to leaks and hacks. The legislation is part of China’s first civil code, a sweeping package of laws that is being deliberated during the annual meeting of China’s National People’s Congress, which began on Friday after a delay of more than two months due to the COVID-19 pandemic. According to a recent draft, an individual has a right to privacy and to have their personal information protected. Data